Orchid Pharma Limited (ORCHPHARMA)

Current Price: ₹0.00

Back to Home
Stock Performance

Quarterly Financials

Consolidated Standalone
Particulars Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Revenue from Operations 209.90 182.92 198.76 220.59 217.10 244.41 222.70 217.34 237.48 172.93 193.52 207.27
YOY Revenue Growth % 16.46% 39.65% 20.28% 38.08% 3.43% 33.61% 12.05% -1.47% 9.39% -29.25% -13.1% -4.64%
Other Income 1.73 1.89 8.18 7.44 12.88 7.77 7.96 9.94 6.26 15.93 15.43 10.59
Total Income 211.63 184.81 206.94 228.03 229.99 252.18 230.66 227.28 243.74 188.86 208.95 217.86
Total Expenses + 155.53 167.12 170.58 198.35 216.52 213.68 215.68 208.21 215.89 170.66 206.72 216.57
Cost of Materials Consumed 104.22 118.41 117.86 135.62 156.47 152.77 153.72 142.02 136.94 110.16 112.27 118.97
Employee Benefit Expense 16.36 16.22 17.19 18.66 17.57 21.37 20.69 22.06 22.24 21.61 24.05 22.88
Other Expenses 34.95 32.49 35.53 44.07 42.49 39.53 41.27 44.13 42.89 38.27 37.64 38.40
Operating Profit 54.37 15.80 28.17 22.24 0.58 30.73 7.02 9.14 21.59 2.27 -13.19 -9.30
OPM % 25.9% 8.6% 14.2% 10.1% 0.3% 12.6% 3.2% 4.2% 9.1% 1.3% -6.8% -4.5%
Profit Before Tax + 65.93 10.78 20.24 30.55 29.96 29.10 25.63 23.91 27.85 18.20 2.23 -5.82
Tax Expense 1.06 0.00 0.00 0.00 -3.23 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Tax % 1.6% 0% 0% 0% -10.8% 0% 0% 0% 0% 0% 0% -
Profit After Tax 64.87 10.78 20.24 30.55 33.19 29.10 25.63 23.91 27.85 18.20 2.23 -5.82
EPS (Basic) 15.89 5.28 4.40 6.42 6.86 5.74 5.05 4.71 5.49 3.59 0.44 -1.15

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021
Revenue from Operations 921.93 819.37 665.90 556.97 450.70
YOY Revenue Growth % 12.52% 23.05% 19.56% 23.58% -
Other Income 31.93 30.39 19.43 9.00 6.48
Total Income 953.86 849.76 685.33 565.98 457.17
Total Expenses + 847.37 752.58 603.76 522.44 408.50
Cost of Materials Consumed 585.46 528.35 406.10 336.80 244.96
Employee Benefit Expense 86.36 69.64 65.35 60.21 64.40
Other Expenses 167.81 154.59 132.31 125.44 99.14
Operating Profit 74.55 66.79 62.14 34.53 42.20
OPM % 8.1% 8.2% 9.3% 6.2% 9.4%
Profit Before Exceptional 106.48 91.52 16.04 -52.77 -95.87
Exceptional Items 0.00 0.00 39.21 0.00 0.00
Profit Before Tax + 106.48 91.52 55.25 -52.77 -95.87
Tax Expense 0.00 -3.23 1.06 -47.96 21.28
Tax % 0% -3.5% 1.9% - -
Profit After Tax 106.48 94.75 54.19 -4.81 -117.15
EPS (Basic) 20.99 19.59 13.28 -1.18 -28.70

Balance Sheet

Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021
ASSETS
Non-Current Assets + 910.19 769.91 729.46 0.00 0.00
Property, Plant & Equipment 612.12 615.12 572.67 0.00 0.00
Capital Work in Progress 27.69 10.18 46.09 0.00 0.00
Non-Current Investments 69.35 69.40 50.12 0.00 0.00
Goodwill 0.00 0.00 0.00 0.00 0.00
Other Intangible Assets 1.13 0.64 0.39 0.00 0.00
Current Assets + 786.39 782.29 493.79 0.00 0.00
Inventories 326.37 264.23 228.74 0.00 0.00
Trade Receivables 241.83 189.37 211.91 0.00 0.00
Cash and Cash Equivalents 15.87 0.29 18.31 0.00 0.00
Current Investments 0.00 0.00 0.00 0.00 0.00
LIABILITIES & EQUITY
Total Equity 0.00 0.00 0.00 0.00 0.00
Equity Share Capital 50.72 50.72 40.82 0.00 0.00
Other Equity 1,273.33 1,167.60 691.15 0.00 0.00
Non-Current Liabilities 135.06 124.21 164.67 0.00 0.00
Current Liabilities 237.47 209.67 326.63 0.00 0.00
Total Liabilities 372.53 333.89 491.30 0.00 0.00

Cash Flow Statement

Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021
Cash from Operating Activities 27.48 130.73 13.39 89.57 0.00
Cash from Investing Activities -37.35 -315.81 -26.70 112.93 0.00
Cash from Financing Activities 25.44 167.07 31.17 -216.80 0.00
Net Increase/Decrease in Cash 15.58 -18.01 17.86 -14.30 0.00